Related Experiment Video
Updated: Feb 6, 2026
09:55
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
951
Positron-emission tomography imaging in urological oncology: Current aspects and developments
Isabel Rauscher1, Matthias Eiber1, Wolfgang A Weber1
1Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Summary
Positron-emission tomography/computed tomography (PET/CT) shows promise in urological oncology, particularly for prostate cancer using prostate-specific membrane antigen (PSMA) targeted tracers. However, 2-[18F]fluoro-2-deoxy-d-glucose PET/CT has limitations in this area.
Area of Science:
- Oncological Imaging
- Urological Oncology
- Nuclear Medicine
Background:
- Positron-emission tomography/computed tomography (PET/CT) integrates functional and morphological data for cancer imaging.
- 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a common oncologic radiotracer but faces challenges in urological imaging due to urinary excretion.
- FDG PET/CT is limited to specific urological indications like seminoma residual disease detection.
Purpose of the Study:
- To review the current status and recent advancements in PET/CT imaging for urogenital system cancers.
- To highlight the evolving role of novel tracers, especially those targeting prostate-specific membrane antigen (PSMA), in prostate cancer imaging.
- To assess the diagnostic utility of different PET/CT tracers in various urological malignancies.
Main Methods:
- Review of current literature on PET/CT applications in urological oncology.
- Focus on the utility of 2-[18F]fluoro-2-deoxy-d-glucose and choline-based tracers.
- Emphasis on the advancements and clinical impact of prostate-specific membrane antigen (PSMA) ligand PET/CT, including 68Ga- and 18F-labeled agents.
Main Results:
- FDG PET/CT has limited value in bladder cancer and requires cautious use or clinical trial participation.
- PSMA-targeted PET/CT has revolutionized prostate cancer imaging, showing superior efficacy for biochemical recurrence detection compared to conventional methods.
- Evidence supports improved staging for primary high-risk prostate cancer using PSMA PET/CT.
Conclusions:
- While FDG PET/CT has specific roles, PSMA-targeted PET/CT represents a significant advancement in prostate cancer diagnostics and staging.
- Newer PET/CT agents targeting PSMA are transforming the management of prostate cancer.
- Further research and application of PSMA PET/CT are crucial for optimizing urological oncology imaging.
Keywords:
bladder cancerkidney cancerpositron-emission tomographyprostate cancerprostate-specific membrane antigentesticular cancerMore Related Videos
Related Concept Videos
01:29Positron Emission Tomography
7.6K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.6K
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
605
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
605
02:39Emission Spectra
76.4K
When solids, liquids, or condensed gases are heated sufficiently, they radiate some of the excess energy as light. Photons produced in this manner have a range of energies, and thereby produce a continuous spectrum in which an unbroken series of wavelengths is present.
76.4K
01:28Urologic Endoscopic Procedure: Cystoscopic Examination
3.1K
Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
3.1K
01:27Imaging Studies III: Computed Tomography
387
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
387
01:30Quantitative Aspects of Drug-Receptor Interaction
1.8K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K